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Visible light has become a highly useful, and regarded, tool to the organic 
chemist. The additions and transformations of an abundance of molecules can be 
achieved with the use of visible light and photocatalysts, when appropriate. More 
specifically compounds that contain nitrogen, halogens, or both are highly useful 
structures in nearly every chemical industry. They are elements found in naturally 
occurring molecules and have the capacity to mimic biologically active and relevant 
structures. This makes them useful targets for pharmaceutical compounds. Bromine and 
chlorine can acts as leaving groups; this property makes molecules with these elements 
reactive and thus able produce desirable effects in vivo. Nitrogen can be found within and 
outside of cyclic structures and is one of the most commonly functionalized elements in 
pharmaceuticals. The element can be found in nearly every class of pharmaceuticals 
ranging from chemotherapeutic to antifungal agents.  
Herein is reported the methodological development of synthetic nitrogen and 
halogen placement through a wide variety of chemical moieties. This work shows that 
visible light and photocatalysts can be used to furnish small heteroatomic compounds and 
halogenated products.  These works highlight the value of substituted hydroxylamines for 
their nitrogen transfer capability; metal-halogen compounds in visible light 
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1.1 Oxaziridine Discovery  
 The first oxaziridine was synthesized in 1956 by William Emmons. He 
accomplished this by reacting azomethines with carboxylic acids. Emmons produced 
oxazidirines, at the time referred to as oxaziranes, with varying substitution patterns on 
the carbon and nitrogen atoms. He observed the surprising stability of the strained ring 
structures and noted their ability to be useful in oxidation reactions when compared to 
organic peroxides (Emmons, 1956). Since this groundbreaking discovery dozens of 
methods to produce oxaziridines have been published.  
1.2 Current Methods 
 The synthesis of oxaziridines is a well explored region of organic chemistry. The 
different substitution patterns make the products useful in for different reactions 
discussed in the next section. As stated above, the first oxaziridine was synthesized and 
characterized by William Emmons in 1956 (Emmons, 1956). This was done through 
oxidation of an imine with peracids and m-chloroperbenzoic acid (mCPBA) and these 
remain some of the most common methods.  
Since this time, dozens of methods have been published detailing the unique 
synthesis of oxaziridines. These methods highlight the ability to create oxaziridines 
synthetically with nearly any substitution pattern imaginable. In 1973 Ogata and Sawaki 
detailed their methods for the synthesis of N-alkyloxaziridines. They were able to 
perform a single step synthesis using peracids to oxidize N-alkyl imines to their 
corresponding oxaziridines. . It is noted besides other oxidizing conditions, such as cobalt 
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and O2, various peroxide systems yield successful results. These products have been 





Figure 1  
 





The Jørgensen group used both aryl and allyl imines and oxidized them with 
mCPBA and a chiral Brønsted base organocatalyst to yield aryl and allyl oxaziridines, 
respectively. The group reported success only with tosyl-substituted imines, owing the 
observed reactivity to the electron-deficient nature of the substrate. These chiral and 
electron-deficient oxaziridines are known to be useful in asymmetric synthesis including 




Figure 2  
 





 Oxaziridines are highly sought after due to their ability to act as organic oxidants. 
N-sulfonyl oxaziridines are commonly used organic oxidants. They are also extremely 
useful in further reactions due to their stability, ease of synthesis, and excellent oxidizing 
ability. Their methods are often revisited to be improved. The N-sulfonyloxaziridines 
became nicknamed the Davis oxaziridine, which Davis et al. synthesized through 
oxidation of the related N-sulfonyl imines with mCPBA. Further research led the Davis 
group to the synthesis of additional N-sulfonyloxaziridines using chiral camphor based 
peracids; however, these were low yielding reactions. The researchers changed their 
approach to synthesizing camphor sulfonic acid derived imines and oxidizing them with 











An underexplored region of oxaziridine synthesis is the synthesis of vinyl 
oxaziridines. Vinyl oxaziridines have the added benefit of an additional reactive points 
within the molecule that can help yield more complex heterocycles in further reactions. 
The Mlochowski group reported a synthesis of these three-membered heterocycles using 
starting materials with a heterocycle conjugated with an unsaturated compound. These 
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substrates were reacted with tert-butylamine in the presence of molecular sieves  to 
produce the aldimine intermediate product. This structure was reacted with mCPBA to 
oxidize into the vinyl oxaziridine. The Mlochowski group reported the presence of a 











1.3 Applications of Oxaziridines 
1.3.1 Oxaziridine-Mediated Oxidation Reactions  
Oxaziridines have become an important class of organic molecules. They have 
proven to be a useful organic oxidant. They are highly useful molecules in heteroatom 
transfer; oxidation and epoxidation can be performed using them. N-
(benzylsulfonyl)oxaziridines can be used to oxidize alkenes into epoxides. 
Oxaziridines have been knowns to oxidize sulfur as well. N-sulfonyloxazidirines 
are useful in the oxidation of sulfides to sulfoxides with the use of optically active 
oxaziridines. Several groups have published methods utilizing N-sulfonyloxaziridines as 
a reagent to oxidize secondary sulfides into sulfoxides; chirality within the reagent helps 
transfer chirality to the final product.  
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The oxidation of amines, enamines, and enolates are possible as well. Along with 
oxidation of various heteroatoms oxaziridines are also able to functionalize carbon-
hydrogen bonds. This process requires high oxidizing power to be successfully achieved. 
Early reports of this chemical transformation were completed using electron-deficient 
oxaziridines. Fluorine-containing oxaziridines have been utilized by several groups to be 
useful in this reaction. More recent reactions have moved away from the use of 
perfluorinated oxaziridines; the Aube group used copper (I) catalyst to oxidize N-










The Shi group was also able to perform a similar oxidation using t-butyloxaziridines as 
the organic oxidant reagent (Williamson, Michealis, & Yoon, 2014). 
Oxidation of sulfur within a compound is also possible. N-sulfonyloxazidirines 
are also useful in the oxidation of sulfides to sulfoxides with the use of optically active 
oxaziridines. Several groups have published methods utilizing N-sulfonyloxaziridines as 
a reagent to oxidize secondary sulfides into sulfoxides; the presence of chirality in the 
oxaziridine has the potential to transfer chirality to the product. Not only is the sulfoxide 
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of interest, but these molecules are also produced with chirality in mind. These reactions 
have been found to be not only successful and scalable but stereoselective, which is of 
particular interest within pharmaceutical production. Some methods have shown 
oxidation to occur within minutes. N-sulfonyl oxaziridines have been used in the 
production of the proton-pump inhibitor rabeprazole (Williamson, Michealis, & Yoon, 
2014).  
1.3.2 Nitrogen Atom Transfer Reactions  
The use of oxaziridines is not limited to the oxidation of heteroatoms; they can 
also be used for heteroatom transfer. The use of N-substituted oxaziridines with small 
groups substituted are useful in the transfers of nitrogen atoms. Being one of the most 
commonly occurring elements in pharmaceutical drugs, nitrogen is a useful element to 
add. More importantly, it is valuable to add nitrogen either already within a cyclic 
structure, or with the potential to easily form a heterocycle in the final product. While 
oxaziridines are unlikely to be found in drug structures themselves, larger heteroatom 
ring sizes are found quite commonly. These are especially common in antibiotics, 
antifungal agents, and anticancer agents. According to Williamson, groups have been 
able to use various techniques to aminate amines, sulfides, alkoxides, and sp3 carbons 
using oxaziridines. The Collet group used oxaziridines to aminate nitrogen nucleophiles. 
A N-carbamoyloxaziridine, designed by the Collet group, was used to aminate primary 
and secondary amines. This approach, while showing good yields, resulted in the 
formation of a competitive byproduct, 4-cyanobenzaldehyde, which occasionally 
decreased overall product yields. However, numerous research groups have used N-Boc-
hydrazine to aminate nitrogen (Williamson, Michealis, & Yoon, 2014).  
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The Armstrong group addressed this reaction utilizing N-Boc-oxaziridine; using 
this oxidant they were able to aminate several primary amines. This reaction yielded N-











Oxaziridines can also be used to the aminate carbon (Armstrong et. al., 2005). N-
sulfonyloxaziridines have been used as starting material by the Yoon group to aminate 
sp3-hybridized carbons to exclusive formation of a nitrogen containing six-membered 
ring. This product can then be used as a starting material in two subsequent reactions to 
add a ketone or an alkene, producing piperidine-containing molecules. The group 
reported no evidence of insertion of the nitrogen into other alkane positions in the product 
(Williamson, Michealis, & Yoon, 2014).  
Nitrogen nucleophiles are not the only nucleophiles oxaziridines can 
aminate.  Under certain conditions they can aminate nucleophilic carbon. Past works have 
shown that the use of N-Boc-oxaziridines with enolates to aminate carbon is mildly 
successful, but byproducts of 4-cyanobenzaldehyde limit the reaction efficiency. The use 
of amide and ester enolates showed similar results. Further research showed that N-Boc-
oxaziridines can transfer nitrogen to organometallic species through a metathesis 
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reaction. It was proposed that nitrogen transfer was favored over oxygen transfer in this 
reaction due to the oxaziridine acting as a Lewis base and the formation of a zincate 
complex. The nitrogen acts as an electrophile and attacks the organozinc complex 
(Williamson, Michealis, & Yoon, 2014).  
 The Collet group also studied aminating sulfides using oxaziridines. Their work 
was met with competitive oxygen transfer which led to lowered yields. However, 
Armstrong and Cooke showed higher levels of amidation could be achieved with the use 










Armstrong and Cooke demonstrated that when the amination of the sulfur occurs, an 
intermediate sulfimide complex forms, which then undergoes [2,3]-sigmatropic 
rearrangement yielding the final amines. The researchers were also able to develop an 
application of this reaction. When amination is applied to chiral allylic sulfides, the 
reaction proceeds with complete chirality transfer. Moreover, Armstrong and Cooke were 
also able to demonstrate the viability of a one-pot strategy to this reaction in good yields 
(Armstrong & Cooke, 2002).  
 When nitrogen transfer is the goal N-H and N-Boc-oxaziridines are both able to 
aminate alkoxides yielding alkoxyamines. The Choong group discovered that 3,3-di-tert-
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butyloxaziridine can be used to aminate primary and secondary alcohols. The steric 
hindrance that accompanies this oxaziridine led to its success in this reaction in good 
yields. However, the steric hindrance of the nitrogen source can also lead to 
encumbrance. This limits its scope, as tertiary alcohol products were isolated in low 










Other research groups were able to produce novel synthetic pathways to achieve this 
oxaziridine-mediated amination. Electrophilic amination of alkoxides was achieved by 
Foot and Knight, utilizing chlorine-based oxaziridines. Their method was shown to 
achieve amination of primary, secondary, tertiary, allylic, propargylic, and phenolic 
alkoxides in good to excellent yields (Williamson, Michealis, & Yoon, 2014).  
1.3.3 Transition-Metal-Promoted Reactions  
While there are an extensive number of methods and oxaziridines that can be 
synthesized, there are even more extensive applications for these oxaziridines. The 
oxaziridine is capable of undergoing rearrangement, specifically initiated by a single-
electron transfer. This property is what leads to the photochemical isomerization of vinyl 
nitrones that will be discussed later in this chapter. Transition metals can also be used to 
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perform these rearrangements and transformations. After his first publication of 
synthesizing the first oxaziridines, Emmons reported the treatment of t-butyl-oxaziridines 
with catalytic concentrations of ammonium iron (II) sulfate in water to yield N-tert-











β-scission cleavage of the oxaziridine could be achieved when using a triethyloxaziridine 
as the starting material. The cleavage yields a mixture of diethyl ketone, N-
ethylpropionamide, and ammonia. The cleavage is believed to follow a nitrogen-centered 
radical intermediate pathway as opposed to the oxygen-centered radical. An oxygen-
centered radical is not as likely given the higher energetic cost of creating this radical in 
situ. The increased stability of the nitrogen radical leads to the single-electron reduction 
of the alkyl chain (Emmons, 1957). 
 The oxidation of imines can lead to amides through an oxaziridine intermediate. 
As reported in Williamson et al., the Black group was able to demonstrate that a similar 
pathway could successfully yield the rearrangement of oxaziridines. The group used 
stoichiometric iron (II) sulfate, and through a nitrogen-radical rearrangement pathway, 
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they were able to synthesize similar amides to those Emmons produced (Williamson, 
Michealis, & Yoon, 2014).  
These catalyzed reactions hold potential outside of the synthesis of 
amides. The formation of nitrogen-containing radicals has also been found to be useful in 
intramolecular cyclization and fragmentations. The Aube group was able to find, while 
studying intramolecular radical cyclization with oxaziridines, that product distribution is 
highly dependent on the substitution of the oxaziridine. They proposed treatment of the 
starting material with 5mol% of copper (I) catalyst would generate the nitrogen-centered 
radical indicative of this rearrangement. This leads to the formation of an aziridine with 











The Aube group also studied nitrogen-radical reactions leading to the formation of 
amides. They found that substitution beta to the nitrogen produces a stable nitrogen-
radical leading to the formation of a stable amide. Moreover, they found the carbon-
radical that forms can be utilized in subsequent reactions (Aube et al., 1992).   
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1.3.4 Oxaziridines in Cycloadditions  
The highly strained nature of oxaziridines is what leads to the observed reactivity. 
Cleavage of the ring can occur at the carbon-nitrogen, carbon-oxygen, or nitrogen-
oxygen bond. The production of cyclic structures within pharmaceutical moieties is 
highly coveted; the rigidity of ring structures allows for the synthesis of products that will 
interact with the desired targets while reducing reactivity in vivo. The addition of 
heterocycles can introduce favorable electronic effects to the structure as well. Several 
cycloaddition reactions can be performed using oxaziridines. The Padwa group utilized a 
thermal rearrangement of an oxaziridine to a nitrone bound to an alkene; they used this 
product to synthesize an isoxazolidine product in good yields. The same product can be 
achieved through the independently synthesized nitrone in similar yields (Padwa & 











It was also discovered the catalytic rearrangement of N-nosyloxaziridines was 
possible. In the presence of catalytic TiCl4 N-nosyloxaziridine isomerizes into the 
nitrone, and when reacted with a terminal alkene a cis 1,2-isoxazolidine was formed. 
When the same N-nosyloxaziridine is reacted with catalytic ScCl2(SbF6) the oxaziridine 
13 
 
isomerizes into a N-nosyl methylamide and when reacted with the same terminal alkene 












Cleavage of the nitrogen-oxygen bond in cycloaddition reactions can lead to the 
production of different isoxazolidines. The use of oxaziridines and alkenes in these 
catalyzed reactions yields 1,3-isoxazolidines; however, uncatalyzed reactions between 
these two substrates are rare. Despite this, the Desmarteau groups reported this same 
reaction uncatalyzed using 1,1-difluoroalkenes producing 1,3-oxazolidine in good yield. 
The Dmitrienko group also observed the oxyamination of 2,3-dimethylindole using N-
sulfonyloxaziridine to form aminal products towards the synthesis of an antitumor 















The production of oxaziridines has also been proven to be successful using 
irradiation of nitrones. It has been known for over a century that nitrones are particularly 
sensitive to light. Alessandri was the first to note the transformation of nitrones via 
visible light conditions (Splitter & Calvin, 1965). The use of light to irradiate nitrones 
opened the doors to new possible structures that could not be oxidized via acid-promoted 
conditions. The dipolar nature of these molecules is what makes them likely to react 
under heat and light conditions, despite being surprisingly stable under standard 
conditions. The zwitterionic nature of nitrones, with the nitrogen carrying a positive 
charge and the oxygen carrying a negative charge, is what promotes the intermolecular 
cyclization into an oxaziridine product.  
1.4 Bioactivity of Oxaziridine-Derived Products 
 Oxaziridines are known to exist as reactive species. The highly strained, three-
membered heterocycle has become known as one of the most useful organic oxidizing 
agents. The different lengths of the bonds between each of the three atoms comprising the 
ring contributes to the reactivity of the molecule. Due to the weakest of the three bonds 
being between oxygen and nitrogen, oxaziridines have a high ability to add nitrogen and 
oxygen to molecules in subsequent reactions. The high electronegativity of these atoms 
contributes to the bond being weak. Oxygen having the greater electronegativity leads to 
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its bond with carbon being the weakest (Vishnu et. al., 2019). Rearrangements, both 
thermochemical and photochemical, yield nitrones and amides.  
The main use of an oxaziridine is in the production of more complex organic 
structures. The predominance of one process over another regarding oxaziridine use as a 
reagent is reflected by the substitution of the nitrogen. Bulky, electron-withdrawing N-
substitutions tend to act as oxygen transfer agents, while small substituents tend to act as 
nitrogen transfer agents (Vishnu et. al., 2019). These molecules are highly non-polar 
structures regardless of the substitution pattern. Electron withdrawing groups substituted 
at the nitrogen electron density is pulled away from the oxygen in the ring, allowing for 
bond breakage. Small substituents do not have this electronic effect, and bond breakage 
no longer favors the carbon-oxygen bond. This is due to the more electron donating 
ability of nitrogen into the oxygen orbitals. While the bioactivity specifically of 
oxaziridines has not been studied, non-polar moieties have increased lipophilicity. The 
increase in lipophilicity can lead to an increase of intracellular concentrations in vivo. 
When oxaziridines are found in natural products they have been known to possess 
antifungal, antibacterial, and chemotherapeutic properties (Said, Młochowski, & 
Skawźewski, 1990).  
1.5 Pharmaceutical Relevance  
Oxaziridines are not common in drug products but can be used to help produce 
final products that may become pharmaceutical agents. Nature can produce these 
structures integrated into complex molecules in a manner that is highly challenging 
synthetically. Natural products that contain oxaziridines possess the potential to be useful 
antifungal and antibacterial agents, as well as anticancer agents (Vishnu et. al., 2019).  
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Natural products are the target molecule of pharmacophores and pharmaceutically 
relevant compounds, with researchers attempting to synthesize these natural products and 
other biologically relevant molecules. For centuries, humans have relied on the 
ecosystem around them as a source of relief from ailment and illness. The bulk of these 
products came from flora and fauna. Although humans no longer rely on their backyard 
as a source of medical relief, medicinal chemistry still takes advantage of the abundance 
of natural products. These natural products offer biological activity found in nature to 
current classes of pharmaceutical compounds. Oxaziridines with electron-withdrawing 
groups are particularly attractive due to the resultant oxyfunctionalization of previously 
unactivated carbon-hydrogen bonds. (Motiwala, Gülgeze, & Aube, 2012)   
While nature has a limited supply of structures it can produce, the synthetic 
chemist can alter a molecule into thousands of deviations. Utilizing natural product 
modeling of molecules known to induce desired effects in vivo allows for a starting 
ground to improve the efficacy of the compound. These natural product-like compounds 
have become popular targets for the improved treatment of many diseases, including 
AIDS, cancer, and infectious diseases (Newman, Cragg, & Kingston, 2015). The ability 
of a man-made molecule to mimic nature’s ability to oxidize carbon-hydrogen bonds has 
been of ever-growing interest.  
The previously mentioned methods for the synthesis of oxaziridines is not even 
the tip of the iceberg in the number of available synthetic pathways. Their reactivity is 
not the only attractive property about them. Oxaziridines tend to be surprisingly stable 
molecules despite their reactivity. Many products have been reported to withstand 
molecular modifications through addition reactions without losing the main functional 
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group; these products also resist decomposition at reduced temperatures. The ease of 
purification through standard chromatographic conditions is an additional attractive 
feature as well (Williamson, Michealis, & Yoon, 2014) 
These molecules can act as oxidants to an asymmetric design which permits 
asymmetric oxidation as well as enantiomerically pure products. Their design affects the 
stereoselectivity influencing which active site is oxidized (Davis et. al This quality to 
yield enantiomerically pure products is highly attractive to pharmaceutical design; 
biological systems are enantiomerically driven systems. The molecules in vivo will only 
yield the desired effects when they are the proper confirmation, otherwise non-desirable 
effects may be experienced if anything at all. The Davis oxaziridine, obtained through the 
imine oxidation of camphor derived carbonyls, can be useful in the asymmetric 
hydroxylation, epoxidation, and oxidation of sulfides (Page et. al., 1997). The synthesis 
of enantiomerically pure oxaziridines is even more useful than the molecule itself. When 
enantiomerically pure oxaziridines are used as oxidants they produce specific molecules 
due to their target attack to certain groups on the substrate molecule (Gioia et. al., 2005). 
The most useful aspect of an oxaziridine lies not in its structural significance in 
biologically active molecules, but the ability to aid in the production of more complex 
molecules. . It owes its reactivity to the highly strained ring structure along with the 
presence of two highly electronegative elements within the heterocycle. They have 
proven to be most useful in oxidative transformations. Despite oxaziridines’ usefulness in 
this area of synthesis, their usefulness in a number of other reactions has also been 
proven. The driving force of these reactions is the heteroatom transfer and the release of 
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ring strain through the formation of carbonyl, imine, or oxometal pi-bonds (Gioia et. al., 
2005).  
These larger nitrogen-containing heterocycles, specifically oxazolidines, 
isoxazolidines, and oxazepines, are commonly found within drugs available on the 
market. Isoxazolidines are non-aromatic heterocycles containing a nitrogen-oxygen bond. 
These structures can produce multi-functional β-amino acid derivatives, including 
alcohols, aldehydes, esters, amides, and imides. They can act as natural building blocks 
for biomolecules (Ayed et. al., 2017). Their concerted ability to act as building blocks 
and produce the derivatives mentioned previously makes them good targets for medicinal 
products. They have demonstrated biological activity including antibiotic capabilities, 
gene expression regulation, and cancer cell toxicity. These last two biological qualities 
make them excellent chemotherapeutic targets (Floresta et. al., 2017). These structures 
can be found as a fused cyclic structure with other cyclic and heterocyclic structures, or 
unfused in pharmaceutical target molecules.  
Oxazolidines are similar to isoxazolidines in that they are oxygen-nitrogen-
containing five-membered heterocycles. However, they differ in the cyclic arrangement. 
In oxazolidines the nitrogen and oxygens atoms are separated by a carbon atom. This re-
arrangement of bond location can have drastic effects on the biological properties of the 
structure. Chiral oxazolidine rings are crucial structures of many natural products. Given 
their chirality and utility they are important to the production of many chiral 
pharmaceuticals (Wu et. al., 2017). Oxazolidines have been known to be useful 
antibiotics, antidepressants, and HIV-1 protease inhibitors (Wang, Yuan, & Yao, 2017). 
Structures responsible for cancer treatment with drug-resistant tumors have occasionally 
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contained oxazolidines. These drugs work through the fragmentation of DNA within the 
cancerous cells (Andrade et. al., 2017). Despite being the most common classes of 
pharmaceuticals oxazolidines can be found in, the structure is observed in nearly every 
class of drug on the market, like many nitrogen-containing heterocylces. 
While the previously two discussed ring structures were both nonaromatic five-
membered rings, the oxazepine is a seven-membered heterocycle. This structure can exist 
as the non-aromatic equivalent, which contains either one or two double bonds within the 
ring, or the aromatic equivalent also referred to as benzoxazepines. Benzodiazepines, one 
of the benzoxapines, are more commonly found in pharmaceutically active agents. They 
display a range of biologically relevant properties and mimicry of natural products. 
Pharmacological properties of these structures worth mentioning include anti-
inflammatory, antifungal, antithrombotic, anti-epileptic, antipsychotic, and 
anticonvulsant properties, as well as analgesic and progesterone antagonistic properties. 
The array of potential physical properties, depending on the substitution patterns of the 
target molecules, are thought to be in part due to the general structure of the ring. A 
nitrogen-carbon-oxygen bond structure is observed in the most common oxazepine 
pharmacophores available today, and this structure is similar to a peptide amide bond. 
The peptide bond is one of the most important and prevalent structural units in biological 
systems, and as such the importance of these rings structures in medicinal chemistry is 
high (Armstrong et. al., 2005).  
Oxaziridines are both valuable intermediates and highly useful reagents in the 
synthesis of larger target molecules. Specifically, they are useful for cycloaddition and 
ring expansion reactions that can be used to produce much more than the heterocyclic 
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structures discussed briefly here. Herein, is described the methods for photochemically 
induced isomerization of vinyl nitrones to vinyl oxaziridines. 
1.6 Results and Discussion 
 Due to the utility of oxaziridines and the limited methods of synthesizing vinyl 
oxaziridines, it was hypothesized that these structures could be achieved through a 
photocatalyzed isomerization of vinyl nitrones. The nitrones were synthesized using a 
previously discovered method. With a library of nitrones available photoisomerization of 
these substrates to form their respective vinyl oxaziridines was pursued. T-
cinnamaldehyde derived nitrones were used for optimization studies; the respective 
oxaziridine was produced in good to excellent yields under visible light conditions 
(Quinn, 2017). Optimization of the isomerization was explored using the nitrones formed 
from 4-phenyl-but-2-enal and cinnamaldehyde. Different sources of visible light were 
explored to find the most useful source for oxaziridine formation. Visible light through 
sunlight by leaving the reaction on a windowsill for 18 hours showed the lowest 
conversion and this method was not pursued further after a single test. Sunlight is not as 
direct as white LED light bulbs and the reaction material is not being excited to a state 
where isomerization occurs. Following conditions included either the use of a white LED 
light in a lightbox with and without catalyst. Benzene and toluene were tested as solvents, 
but without the use of a photocatalyst due to the conjugated nature of the compounds. 
This property allows the molecules to absorb and emit wavelengths of light allowing 
them to play a part in the excitation state of the intermediate. With the exclusion of using 
sunlight as the light source, the previously tested reaction conditions were repeated using 
cinnamyl nitrone. Using both substrates the test for ideal conditions it was found that the 
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Completion of a scope containing vinyl oxaziridines formed from aldehyde 
derived nitrones was pursued. The range of substitution patterns explored on both the 
conjugated aldehyde and hydroxylamine used to produce the nitrone highlights the 
versatility of the reaction scope. One trend that can be noticed is there is a slight 
difference in the trend of isomerization between the aromatic oxaziridines formed and the 
allylic oxaziridines formed. While yields were still great in both substrate categories 
overall, the aromatic oxaziridines showed higher yield in comparison to the allylic 
oxaziridines. The conjugated nature of aromatic compounds, and the lower overall energy 
state they exist in, contributes to the higher conversion observed with these substates. All 
oxaziridines were isolated using manual column chromatography. Being highly polar 
















































The results obtained show a simplistic method for the conversion of nitrones to 
oxaziridines through a visible light irradiation photocatalytic processes. The GML lab 
was able to demonstrate a wide range of chemical diversity by utilizing t-cinnamaldehyde 
derived nitrones with various hydroxylamines. The wide range of substitutions patterns 
explored on both the conjugated aldehyde and hydroxylamine used to produce the nitrone 
highlights the versatility of the reaction scope. One trend that can be noticed is there is a 
slight difference noticed in the  isomerization between the aromatic oxaziridines formed 
and the allylic oxaziridines formed. All oxaziridines were isolated using manual column 
chromatography. As highly polar compounds, they were relatively simple to isolate. This 
method boasts the utility of not only substituted hydroxylamines in the synthesis of 
heteroatomic moieties, but also visible light in the pursuit of more complex molecular 
scaffolds.  
1.8 Experimental 
Reagents were obtained from Aldrich Chemical, Acros Organics and Alfa Aesar 
and used without further purification.  Reactions were performed in 4- mL glass vials. 
TLC was performed on 0.25 mm E. Merck silica gel 60 F254 plates and visualized under 
UV light (254 nm) or by staining with potassium permanganate (KMnO4). Silica flash 
chromatography was performed on E. Merck 101 230–400 mesh silica gel 60. Automated 
chromatography was performed on an ISOLERA Prime instrument with 10 g. SNAP 
silica gel normal phase cartridges using a flow rate of 12.0 mL/min and a gradient of 0–
30% EtOAc in Heptanes over 12 column volumes with UV detection at 254 nm. NMR 
spectra were recorded on Varian Mercury II 400 MHz Spectrometer at 24 °C in CDCl3 
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unless otherwise indicated. Chemical shifts are expressed in ppm relative to solvent 
signals: CDCl3 (1 H, 7.23 ppm; 13C, 77.0 ppm); coupling constants are expressed in Hz.  
1.8.1 General Method for the Synthesis of Vinyl Oxaziridines  
1mMol of nitrone is dissolved in 30mL of Benzene to a 0.1M solution. Solution 
delivered to a 50mL round bottom flask (borosilicate) UV cutoff approximately 300nM. 
Nitrone solution is irradiated under a 105-Watt Compact Fluorescent Lamp (Limo Studio 
Full Spectrum Light) for 6 hours. After irradiation, the solvent is reduced by rotary 
evaporation to afford the respective oxaziridine. Filtration by silica gel with 20% EtOAc 
in Heptanes over 12 column volumes provided the desired oxaziridine in good to 
excellent yields.  
1.8.2 Synthesis of Vinyl Oxaziridines  
Due to the COVID-19 pandemic of spring 2020 incorporation of data analysis, 





















Haloamines and Aromatic Bromides  
2.1 Haloamine Discovery  
 Haloamines are molecules containing both a halogen and an amine group. This 
includes N-haloamines, molecules where the halogen is bound directly to the nitrogen, 
vicinal haloamines, where the amine and halogen are on adjacent carbons, and molecules 
containing both functional groups in remaining substitution patterns. The use of these 
compounds can be dated back to 1883, first cited in the Hofmann-Löffler reaction. 
Hofmann utilized N-bromoamides and N-bromoamines to perform an intramolecular 
cyclization to produce tertiary amines; this method became a quick and simple process 
for the synthesis of pyrrolidines. Later, Löffler expanded on this process, and found that 
alkyl bromoamines failed to yield the same results Hofmann produced. However, he 
found that alkyl chloramines could be utilized to form the same pyrrolidines Hofmann 
synthesized (Corey & Walter, 1960). 
Even more useful than the Hofmann-Löffler reaction is the dozens of alkene 
difunctionalization reactions discovered within the last century. More specifically is the 
1,2-functionalization of alkenes with amines and halogens. The derivatives of these 
reactions are useful in subsequent reactions towards the synthesis of more highly 
complex molecules in medicinal and organic chemistry (Thakur, Talluri, & Sudalia, 
2003). 
2.2 Current Methods  
Many groups have studied methods to produce haloamines. The Chemler group 
studied several catalytic processes for making these molecules starting with alkenes, 
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allenes, and alkynes to yield vicinal haloamines using fluorine, bromine, and chlorine. 
Their method was shown to not only be successful, but regioselective, diastereoselective, 
and enantioselective as well. The catalyst varied depending on halogen added in the 
reaction they were studying, but all catalysts used were transition metal based. Methods 











 Production of haloamines is not limited to starting with an alkene. Li discovered 
the use of α-β-unsaturated carboxylic esters and ketones under various catalytic 
conditions. This reaction is believed to follow an aziridinium-based intermediate 
mechanism. The cyclopropane starting material was reacted with 20 mol% iron (II) 
chloride in acetonitrile at room temperature; this method gave good to excellent yield 
depending on the substitution pattern of the starting substrate. The reaction scope showed 
the presence of electron-donating groups on the cyclopropane gave higher conversion 
rates, aiding in cleavage of the ring. Products with highly electron donating groups 
containing a halogen could continue to be reactive species in future reactions, as the 












 Aminohalogenation can be performed using various nitrogen and halogen sources 
from amines, amides, sulfonamides, carbamates, and imides. Addition of the two 
functional groups across the alkene can occur through heterolytic or homolytic cleavage. 
Homolytic cleavage can be initiated by peroxides, light, or heat.  
2.3 Applications of Haloamines 
Compounds containing both a halogen and an amine functional group are 
attractive molecules due to their similarity to molecules with bioactivity that occur in 
nature. Haloamines can be found as secondary metabolites; secondary metabolites are 
molecules that are produced by bacteria, fungi, and plants that while not necessary to 
sustain life, increase the survivability of the organism. The importance of these molecules 
lies in their activity. The propensity of the halogen to act as a leaving group contributes to 
the usefulness of haloamines in cross-coupling and substitution reactions (Chemler & 
Bovini, 2013). 
Most notably, haloamines are highly useful in the steps to synthesize a piperidine 
heterocycle fused with a five-membered carbocyclic ring. This fused cyclic structure is 
an alkaloid system that presents biological activity; the product is formed through the 
Pauson-Khand reaction which is a [2+2+1] cycloaddition where a triple bond, double 
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bond, and carbon monoxide react to form a cyclopentenone. The Pauson-Khand reaction 
is most useful in its construction of greater molecular complexity in a single step 
(Blanco-Urgoiti et. al., 2004).  Recent works have focused on the intramolecular 
bicyclization of molecules containing both an alkene and alkyne functional group to 
create this fused ring structure, and eventually natural products (Llobat et. al., 2020). The 











2.4 Antimicrobial Properties of Halogenated Molecules 
Halogenated species are also useful as antimicrobial agents due to their ability to 
act as strong oxidizers. An aqueous solution of bromine readily reacts with nitrogen 
sources to form bromoamines, which possess antimicrobial properties (Ji et. al., 2013). 
Bromine containing compounds have been found to be useful in the treatment of medical 
devices and equipment. Due to their antimicrobial properties, molecules such as 
Bronopol have been designed as antibacterial agents that do not react within the body 
with undesired side effects (Bryce et. al., 1978). 
While vicinal haloamines are the products being formed in the reaction studied, 
they are not the only haloamines that can be formed. N-haloamines can be formed 
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through the electrophilic addition of N-X compounds to alkyl groups. These compounds 
are capable of reacting with carbon-based nucleophiles. N-haloamines can also be used in 
the synthesis of primary, secondary, and tertiary amines (Erdik & Ay, 1989) These 
amines can potentially be used later in the pursuit of nitrogen-containing heterocycles 
with further applications and potential amino acid derivatives. 
 Despite this, chlorine is still the most abundant water antiseptic agent used. 
Chlorine containing molecules are commonly used to sterilize water for public and 
private pools, and municipal and industrial water supplies. Chlorine containing 
compounds are also used to reduce the growth of microorganisms on medical devices and 
equipment. These tend to be liquid chlorine and hypochlorite, but recent research has 
found that organic chloramines are just as effective at inactivating microorganisms. 
Iodine has been used for its antiseptic properties but is only used in its elemental form; 
fluorine is not seen as an antimicrobial agent (Odlaug, 2009). The other major drawback 
to elemental iodine used as an antimicrobial agent is the compound can only be used for 
external use and does not have the same in vivo characteristics. 
 One of the most important characteristics of haloamines is the synthesis of more 
efficient antibiotics to treat drug-resistant infections. Developing drugs useful against 
harmful bacteria has become of increasing importance due to the rise in cases of drug 
resistance bacterial infections. Infections such as MRSA, multidrug-resistant 
staphylococcus aureus, and MDR-TB, multidrug-resistant tuberculosis, have become 
problems in developing and developed countries alike. Designing drugs intended to 
mediate these issues has been met with many challenges. These challenges can be 
attributed to not only the bacterium's resistance to traditional bactericides, but also the 
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structure of their cells (Exner et. al., 2017). Most drug resistant bacteria are gram 
negative, which have outer membranes that allow for selective permeability. This makes 
penetration of antibacterial agents more difficult and specificity is necessary. 
Incorporating new pharmacophore groups as well as introducing novel mechanisms of 
actions have been the two most explored methods to alleviate this epidemic (Exner et. al., 
2017 &, Benson et. al., 2020).  Multidrug resistance is defined as “the resistance to at 
least one agent in three or more antimicrobial categories”. The reservoir of introduction 
of drug-resistant microorganisms comes in varying forms, however the impacts it has on 
healthcare, medicine, and economic resources is huge (Exner et. al., 2017).  
 The influence halogen-containing compounds have on the antibacterial properties 
of flavonoids has been documented. Flavonoids are secondary metabolites found in plants 
with antioxidative properties. These compounds have extended bioactivity outside of this 
that make them attractive structures to synthesize for pharmaceutical purposes. Various 
flavonoids have been found to have any of the following properties: anticancer, anti-
inflammatory, antiviral, antifungal, and antibacterial. It’s known that flavonoids can 
exhibit antibacterial properties, but the structures that Stefan and Birsa studied were not 
known to show antimicrobial properties. Tricyclic flavonoids used in their research were 
known to be selective estrogen receptor-β agonists with no related tricyclic structures 
known for antibacterial capabilities in the literature. Stefan and Birsa showed the 
antibacterial potential of these structures when halogens were inserted into the structure 












 They found that the introduction of halogen groups or hydrogen to the two R 
positions indicated in the structure above showed the greatest antibacterial properties of 
all the modifications made to the ring. It was also observed that the size of the halogen 
directed the efficacy of the structures. Halogen substitutions of fluorine were least 
effective against S. aureus and E. coli, while iodine substitutions were the most effective. 
Regardless of this, bactericidal properties noticeably increased when the atom bound 
went from a hydrogen to a halogen. A second series of biological tests were done where 
substitutions were made at both R group positions. These tests showed the same trend, 
the presence of a smaller group at these positions led to decreased antibacterial activity. 
These compounds, which showed antibacterial efficacy, were compared to Kanamycin 
and Ampicillin and showed similar if not better results. Stefan and Kirsa believe 
antibacterial properties of the halogenated flavonoids is influenced most by the size of the 
halogen substituted (Bahrain et. al., 2016). Due to the high level of specificity required to 





2.5 Bioactivity of Haloamines 
 The synthesis of highly complex organic molecules has led increasingly towards 
hybrid structures consisting of two or more pharmacophore groups in one molecule. 
Doing so allows for the formation of a new compound with potentially high biological 
activity, varied selectivity, and possibly reduced side effects. Pharmaceutical chemistry is 
constantly in the pursuit of designing new biologically active compounds using structures 
and substructures found in known drugs and nature alike. Structures containing nitrogen, 
specifically amines, are the most common heterocyclic atoms found in pharmaceutical 
products on the market. One of the most attractive qualities of halogens being 
incorporated into biologically active molecules is their ability to halogen bond and how 
this changes their in vivo interactions. 
2.6 Halogen Bonding in Vivo 
 An attractive property of halogen containing molecules is how they interact with 
cell membrane receptors and biomolecules when introduced in the body. Halogens bound 
to a carbon can interact with other molecules through halogen bonding, an intermolecular 
force similar to hydrogen bonding that occurs between specific heteroatoms and 
halogens. The halogen usually undergoes this interaction between nitrogen, oxygen, and 
sulfur containing functional groups on adjacent molecules. Due to the halogen groups 
innate ability to participate in a pseudo-bonding event it has become more attractive to 
add halogens to pharmaceutical compounds in an effort to increase efficacy in vivo (Xu 
et. al., 2014). The carbon-halogen bond serves as an electron-deficient structure in a 
molecule that can interact with a nucleophilic region of another molecule. The directional 
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ability of bonding, it is specific in its three-dimensional orientation, making it an ideal 
binding interaction to occur between a drug and its binding target in the body (Yang & 
Wong, 2020). 
Yang et. al. theorized how this electrostatic interaction is occurring. It is believed 
that this occurs in a planar, linear fashion and due to the high electron density of the 
nucleophilic species involved and electron-deficiency of the halogen causing a sigma 
hole to form. The magnitude of this sigma hole depends on how polarizable the halogen 
is, with iodine being the most polarizable and fluorine being the least polarizable, and 
how electron-withdrawing the atom bound to the halogen is (Yang & Wong, 2020).  The 
polarizability of the element and the electron-withdrawing capability of the other atom 
creates an electrostatic potential throughout the attractive force, with greater electrostatic 
potential being created when halogens with higher polarizability are involved with 
bonding; the larger the electrostatic potential the stronger the bond interaction. However, 
this is with the caveat that fluorine’s polarizability is so low that halogen bonding can 
only occur between groups that are strongly electronegative (Xu et. al., 2014).  
Another theory, still under further investigation, explaining halogen bonding 
involves electron orbital structure. P orbitals have 3 electron nodes, each with a capacity 
of 2 electrons with opposite spin. Halogens have 1 lone electron in their valency, which is 
housed in the z node of their P orbital. This configuration depletes the distribution of 
electron charge in the planar direction, compared to the free halogen, promoting the 
formation of the sigma hole characterized in halogen bonds. The sigma hole promotes a 
positive electrostatic interaction between the electron donor and acceptor. (Franchini et. 
al., 2020).  
36 
 
The driving force behind this interaction could also be explained by molecular 
orbital theory. The lowest unoccupied molecular orbital (LUMO) of the halogen-electron 
donor complex interacts with an electron pair in the highest occupied molecular orbital 
(HOMO) on the nucleophile. The HOMO-LUMO interaction leads to a lower energy 
stabilization of the bonding interaction between the two atoms. Therefore the interaction 
is stronger the larger the halogen, as the valence electrons of larger radii are stabilized 
through the HOMO-LUMO interaction (Yang & Wong, 2020). Despite the working 
theories that explain this coveted interaction, halogen bonding is a phenomenon that has 
been observed, and plays a key role in how halogen-containing-molecules interact within 
chemical space, being particularly important to the pharmaceutical significance 
halogenated molecules. The ability to incorporate halogen bonding to interactions with 
target receptors and enzymes within the body may aid in the increased efficacy and 
distribution of pharmaceutically relevant compounds. 
2.7 Pharmaceutical Relevance 
Haloamines are important building blocks in organic synthesis; 
difunctionalization of alkenes and alkynes can be achieved through catalytic addition of 
these two functional groups. This allows for a greater order of desired reactivity and more 
control to the desired product. The chemical properties of target molecules can be 
controlled to a degree through this approach. By controlling the chemical properties of 
lead molecules, the pharmaceutical activity of the molecule can be controlled more 
easily. This practice is used when using the receptor’s and enzyme’s endogenous ligands 
target is the structure the lead molecules are based upon. Many drugs have been 
discovered through this route, especially estrogen and progesterone-based contraceptives. 
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This type of approach can also be seen in the ingenious design of prodrugs and drugs 
with secondary biologically activity after metabolism. Even haloamines of non-natural 
origin have been found to have significant biological activity, and shown to be successful 
DNA alkylating agents (Chemler & Bovini, 2013) 
 Molecules that contain halogens also can create halogen bonds with other 
molecules. Halogen bonding has been found to be like hydrogen bonding, an electrostatic 
reaction between a halogen bound to a carbon,  and a nucleophile on a neighboring 
molecule. The dipole moment created between the carbon and the halogen creates an 
extension of the electrostatic region allowing for interactions with the appropriate 
functional groups. The ability to create molecules with the capability of this, despite not 
being well understood, allows for increased potential of the versatility of the halogens in 
medicinal chemistry. This can only increase the drug-target binding affinity; the higher 
the affinity the more competitive towards the endogenous receptor. Interactions that 
occur between these molecules are increased, leading to higher stability of the ligand-
target complex which prompts for a favorable interaction. 
 Recent studies have highlighted the importance of halogen bonding in medicinal 
compounds. Within the body organohalogens are believed to take part in halogen 
bonding with endogenous proteins being involved in all the biological processes a drug is 
exposed to in vivo. They are capable of interacting with all proteins, as they most 
commonly undergo this interaction with oxygen, nitrogen, and sulfur groups (Xu et. al., 
2014). It has been characterized that iodine, within the thyroid, exploits the use of its 
ability to halogen bond with oxygen-species. These interactions play a huge role in the 
recognition of hormones within the thyroid. This characteristic can be exploited in drug 
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design. Aldose reductase-inhibitors are already known to use this mechanism by 
interactions between a bromine on the inhibitor and an oxygen on the aldose ligand, 
preventing the binding of the reductase protein (Auffinger et al., 2004).  
Halogen bonding is no stranger to biomolecular interactions. It’s estimated that at 
least 25% of the drug market is made up of organohalogens, and it is hypothesized that 
halogen bonding plays a role in at least one of  their ADME properties (Xu et. al., 2014). 
Here is described the methods currently being studied in the GML lab to brominate 
styrenes and stilbenes in a visible-light promoted radical-mediated mechanism. 
2.8 Results and Discussion 
 Given previous reactions studied in the GML group the haloamination of alkenes 
alpha to aromatic species was pursued. The reaction was optimized based on the methods 
in which the reaction was desired to take place. Styrene was used in initial optimization 
studies with iron (II) bromide. Previous reactions relied on a heat driven reaction, and 
despite the efforts to aminate the product, amination has not been observed through 
spectral or analytical data. However, with the desire to utilize visible light the review of 
viable photocatalysts was performed. Organocatalyst studies showed the use of 
ruthenium-tris(2,2’-bipyridyl) dichloride was most successful in achieving high 


















With favorable catalyst conditions a scope was explored for this reaction. 
Styrenes and stilbenes were reacted with hydroxylamine-o-sulfonic acid and iron (II) 
bromide under photocatalytic conditions afforded diastereomeric brominated products in 
good yields. However, crude NMRs showed the formation of several uncharacterized 
side products. Due to the long reaction period (48 hours) of this reaction the temperature 
of the light box was explored, and reactions were being heated to 47oC. It was theorized 
that the temperature was a major contributor to the formation of undesired products.  
A ventilation fan was installed on the light box which cooled the internal 
temperature to 27oC removing heat from being a factor in product formation. Reactions 
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ran after the installation of the fan showed crude NMRs with less side products and 
higher product formation. It is hypothesized that the ventilation and cooling of the light 
box allowed for the prominent mechanism to control product formation.  
 The previously studied reactions utilized toluene as the solvent at 0.1M 
concentration, and due to the success of the visible light reaction under the same solvent 
system this condition was used. Now the scope was fully explored. The reaction proved 
successful in good to excellent yields to transform styrenes and stilbenes into their 
corresponding brominated product. The reaction led to the formation of regioisomeric 













Isolation of the product mixture was unsuccessful at the start. The mixture did not 
appear by NMR to elute through a silica gel column, both in manual and automatic 
columns. Considering the unfruitful efforts of standard purification methods, and the 
theory that the product was binding with silica gel in the column, preparatory TLC was 
attempted. Much to our excitement this method was successful in isolating the 
regioisomeric product mixture. Efforts to utilize this technique to separate the mixtures 
proved unsuccessful.  
 With an interest in separating the regioisomers for spectral analysis and 
confirmation, HPLC conditions were tested to determine if the products could be 
separated with this technique. A 1mg/mL sample of pure mixture in acetonitrile was 
prepared. Separation conditions were tested on a reverse-phase HPLC. Separation was 
first tested with 40% H2O to 60% H2O with acetonitrile as the organic phase over 20 
minutes. The first injection showed two distinct peaks, albeit overlapping with each 
other. With analytical data showing two peaks conditions were adjusted to isolate each 
peak. After several trials the chromatograms showed separation of each isomer with 
conditions where a 20% to 80% acetonitrile mobile phase over 25 minutes was used. A 
small peak was observed with a retention time of 10 minutes, the smaller regioisomer 
equivalent, and the remaining product showed a retention time of 20 minutes under this 
mobile phase. Due to lack of access to a preparatory HPLC to isolate the components of 
the mixture the completion of this method has been postponed until access to the proper 

























 Styrenes and stilbenes were converted to their respective aromatic α-bromides 
while showing good to excellent product formation. Complete consumption of the 
starting material was consistently observed; where this was not observed, the product was 
still formed in good to great yields. This method provides a wide scope showing 
transformation of a double bond to a saturated substrate. The use of visible light led to the 
increased integrity of the functional groups and subsequent products that may not be 
guaranteed with other methods.  Further research may include incorporation of acyclic 
systems to further understand the contribution of the electronic system of aromatic 
substrates in the reaction.  
 The lack of a preparatory HPLC for use in separating the regioisomers formed 
with this method has impeded the full completion of this project. Due to this most 
product mixtures formed have not yet been isolated through use of preparatory TLC, but 
the crude reaction medium was isolated through rotary evaporation and frozen in benzene 
to be completed at a date following access to a preparatory HPLC. As such, products 
discussed further will not include pure data. Upon acquiring pure yields (mixtures and 
isolated diastereomers) the electronic and steric effects of the benzylic starting materials 
may be studied further to better understand their impact on the method outcome. This 
may lead to a better understanding of the mechanism that leads to the product ratios, and 
why ratios differing for each substrate has been observed.  
2.10 Experimental 
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar 
and used without further purification.  Reactions were performed in 20- mL glass vials 
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with magnetic stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 
plates and visualized under UV light (254 nm) or by staining with potassium 
permanganate (KMnO4). Purification was performed by preparatory TLC on silica gel 60 
F254 preparatory TLC plates (1mm silica gel thickness, 10 - 40 μm) in 25% EtOAc in 
heptanes mobile phase and run 3 times and visualized under UV light (254 nm). Product 
mixture was isolated through collection of UV active spots on the preparatory TLC plate, 
sonicated while suspended in DMC, and gravity filtered. The dissolved pure mixture was 
isolated through rotary evaporation to afford the respective mixture. NMR spectra were 
recorded on Varian Mercury II 400 MHz Spectrometer at 24 °C in CDCl3 unless 
otherwise indicated. Chemical shifts are expressed in ppm relative to solvent signals: 
CDCl3 (1 H, 7.23 ppm; 13C, 77.0 ppm; coupling constants are expressed in Hz). 
2.10.1 General Methods for the Synthesis of Aromatic Bromides  
In a 20mL glass vial, 100mg styrene or stilbene, 2 mmol eq. of hydroxylamine-o-
sulfonic acid, and 1 mmol eq. of iron (II) bromide were dissolved in 0.1M toluene with 
1mL 2.5mol% ruthenium tris(2,2’-bipyridyl) chloride dissolved in acetonitrile. The 
mixture was stirred on high at room temperature in an enclosed visible light box with a 
ventilation fan for 48 hours. Iron and ruthenium reaction complexes were removed from 
the mixture by vacuum filtration through 1:1 silica:celite and washed with excess ethyl 
acetate. The mixture was concentrated by rotary evaporation to afford the crude product. 
The crude product mixture was isolated through preparatory TLC in 20% ethyl acetate in 
heptanes; the preparatory TLC was run three times to ensure separation of the pure 
regioisomer mixtures. The product mixture are to be separated through preparatory HPLC 
to afford pure regioisomers.  
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2.10.2 Synthesis of Aromatic Bromides from Table 6  
Due to the COVID-19 pandemic of 2020 data available for the bromination of 
alkenes alpha to aromatic rings. All NMR data was based on crude NMR; the GML lab 
does not currently have access to a preparatory HPLC which hinders the completion of 




1-(1-bromoethyl)-4-(tert-butyl)benzenea; 1-(2-bromoethyl)-4-(tert-butyl)benzeneb:  
1 H NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 
(d, J = 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 
8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn 
O O (T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 Hz, 1H), 3.63 (d, J = 7.4 Hz, 1H), 




(1-bromoethyl)benzenea; (2-bromoethyl)benzeneb: 1 H NMR (400 MHz, CDCl3) δ 
9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 
(m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 
Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 




1-(1-bromoethyl)-4-methoxybenzenea; 1-(2-bromoethyl)-4-methoxybenzeneb: 1 H 
NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J 
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= 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 
1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O 
(T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 Hz, 1H), 3.63 (d, J = 7.4 Hz, 1H), 3.35 




1-(1-bromoethyl)-4-methylbenzenea; 1-(2-bromoethyl)-4-methylbenzeneb: 1 H NMR 
(400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 
Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 
4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) 





2-(1-bromoethyl)-1,3-dichlorobenzenea; 2-(2-bromoethyl)-1,3-dichlorobenzeneb: 1 H 
NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J 
= 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 
1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O 
(T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 Hz, 1H), 3.63 (d, J = 7.4 Hz, 1H), 3.35 




1-(1-bromoethyl)-3-nitrobenzenea; 1-(2-bromoethyl)-3-nitrobenzeneb: 1 H NMR (400 
MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 
1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 
(dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-






1-(1-bromoethyl)-2-fluorobenzenea; 1-(2-bromoethyl)-2-fluorobenzeneb: 1 H NMR 
(400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 
Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 
4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) 





(2-bromopropan-2-yl)benzenea; (1-bromopropan-2-yl)benzeneb: Purification by 
silicon gel 60 F254 preparatory TLC (1mm silica gel thickness, 10 - 40 microm, 25% 
EtOAc in heptanes mobile phase, run 3 times) yielded the brominated benzylic product 
1b (115 mg, 90%) as a yellow oil. 1 H NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 
Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 
15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 
(m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 




1-(1-bromoethyl)-3-chlorobenzenea; 1-(2-bromoethyl)-3-chlorobenzeneb: 1 H NMR 
(400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 
Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 
4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) 










(chloromethyl)benzeneb: 1 H NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 
7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 
1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 
3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 Hz, 1H), 




2-(1-bromoethyl)naphthalenea; 2-(2-bromoethyl)naphthaleneb: 1 H NMR (400 MHz, 
CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 
6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J 
= 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 




(2-bromopropyl)benzenea; (3-bromopropyl)benzeneb: 1 H NMR (400 MHz, CDCl3) δ 
9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 
(m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 
Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 







4-(1-bromoethyl)-2-methoxyphenola; 4-(2-bromoethyl)-2-methoxyphenolb: 1 H NMR 
(400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 
Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 
4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) 





(1-bromopropane-1,2-diyl)dibenzenea; (2-brompropane-1,2-diyl)dibenzeneb: 1 H 
NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J 
= 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 
1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O 
(T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 Hz, 1H), 3.63 (d, J = 7.4 Hz, 1H), 3.35 




(1-bromoethane-1,2-diyl)dibenzene: 1 H NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 
0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, 
J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 
4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 







phenylethyl)phenyl)methanolb: 1 H NMR (400 MHz, CDCl3) δ 9.76 (dd, J = 2.4, 0.6 
Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 (m, 2H), 6.61 (d, J = 
15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 Hz, 1H), 4.16 – 4.09 
(m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 3H), 3.78 (d, J = 14.1 




(3-bromobutyl)benzenea; (4-bromobutyl)benzeneb: 1 H NMR (400 MHz, CDCl3) δ 
9.76 (dd, J = 2.4, 0.6 Hz, 1H), 7.38 – 7.32 (m, 6H), 7.29 (d, J = 10.0 Hz, 1H), 6.89 – 6.86 
(m, 2H), 6.61 (d, J = 15.8 Hz, 1H), 6.09 (dd, J = 15.8, 8.5 Hz, 1H), 4.24 (dd, J = 8.9, 4.0 
Hz, 1H), 4.16 – 4.09 (m, 2H), 3.82 (d, J = 0.6 Hz, N Bn O O (T7A) EM-141 MeOPh 75 















Fluorination of Activated Styrenes and Stilbenes 
3.1 Fluorine - Discovery and First Uses 
 In 1835 the first reaction resulting in the formation of a synthetic organofluorine 
compound was carried out. Dumas et. al. reported the synthesis of methylfluoride 
compounds prepared from dimethyl sulfate and potassium fluoride. In 1862 Alexander 
Borodin reported the first nucleophilic halogen exchange reaction using benzoyl chloride 
and potassium fluoride. The halogen exchange reaction has become one of the most 











Despite these initial synthetic discoveries, mineral fluoride was discovered and 
used as early as the 1500’s. It took another 200 years for the characterization of the new 
element, fluorine, to occur. It took over 300 years from its original recognition for 
elemental fluorine to be isolated. The element was successfully isolated by Moissan who 
used electrolysis on a melt mixture of potassium hydrogen difluoride and hydrogen 
fluoride. Due to the highly reactive nature and safety hazards of the element 
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organofluorides were not utilized in industry until the 1920’s (Okazae, 2009, & Filler & 
Saha, 2009).  
Prior to industrial uses fluorine compounds were used in the 16th and 17th 
centuries for glass etching. From here the usefulness of fluorine-containing compounds 
became known in the 1920’s. Aliphatic fluorides were introduced as inert refrigerants in 
1928, the late 1920’s and early 1930’s brought about Freon. Soon after fluoroplastics 
began to develop and find their way into the general population (Okazoe, 2009). 
3.2 Current Fluorination Methods 
 With few exceptions, fluorine is not naturally occurring in a chemical compound. 
However, fluorine has many chemical and physical properties that make it an attractive 
atom to add to a compound, coupled with the increased bioactivity this element brings to 
compounds it is bound to make methods for the fluorination a highly sought after 
endeavor. Fluorine gas has a recognized radical reactivity due to the weak bond between 
the two atoms. The high electronegative nature of the element contributes to the weak 
bond when in diatomic form, allowing for homolytic cleavage (Okazae, 2009, & 
Chatalova-Sazepin et. al., 2015).   
 The Kollonitsch group showed that benzene, when reacted with trifluoromethyl 
hypofluorite, could be fluorinated under UV irradiation in good yields. They showed this 
was also successful with cyclohexane. The group was able to prove that the reaction was 















Fluorination of compounds is not limited to addition reactions. Patrick et. al. reported the 
use of xenon difluoride as a reagent in a substitution reaction. The group reacted to 
aliphatic carboxylic acids in chloroform to produce a mixture of open-chain terminal 











 Fluorinated nitrogen sources could also be used as viable sources of atomic 
fluorine. Commercially available N-fluorobenzenesulfonimide (NSFI) is frequently used 
due to the stability of the molecule and the ease of handling the fluorine source. The 
reagent readily radicalizes in reaction. Sammis, Paquin, and Kennepohl theorized this 
could be used as an atomic source of fluorine to fluorinate tertiary peresters. Using NSFI 
they were able to perform a radical-mediated fluorination of diacyl and tertiary peresters 
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under both thermal and photochemical conditions. The reaction was performed on 
starting materials where R was equivalent to primary, secondary, tertiary, alkyl, and 
benzyl substrates. Through this method they were able to produce complex steroid 
derivatives through the formation of a radical alpha to the heteroatom as well (Chatalova-











 Selectfluor, an electrophilic positively charged bridged piperazine fluorine source, 
can also be used in the presence of silver catalyst to perform a decarboxylation and 
subsequent fluorination at the same site. In fact, it is one of the most utilized sources of 
radical atomic fluorine in synthetic chemistry. The quenching of the positive charge on 
the nitrogen when the fluorine leaves drives the formation of the highly electrophilic 
fluorine. Being the most electronegative element, electrophilic fluorine will react with the 
most accessible nucleophilic source in situ. This method was used by the Su group in the 
pursuit of improving the synthesis of fluticasone propionate. The Pohmakotr group also 
reported using the same silver catalyst in a similar manner to β-fluorinated butyrolactones 










Sammis and Paquin also reported the use of UV light to decarboxylate and fluorinate 2-
aryloxy and 2-aryl carboxylic acids. The substrate is pushed into an excited electron state 
and Selectfluor oxidizes, decarboxylates and finally fluorinates the alkyl radicals  
successfully in good yields. They also reported the same product formed when the 
aryloxy compounds were treated with 2,6-di-tert-butyl-4-methylpyridine and NFSI were 
used as a mild oxidizing agent under 300-350nm wavelengths light (Chatalova-Sazepin 






















Method 2 of the Sammis and Paquin’s Photofluorodecarboxylation of Aryloxy Acids 
 
 
 While adding fluorine to a compound has proven challenging, once completed a 
carbon-fluorine bond is the strongest bond available. Fluorination is not limited to the 
functional groups that are most reactive. Fluorination of alkenes and alkynes can also be 
performed. The Boger group was the first to report a radical fluorination of alkenes with 
the use of Selectfluor. The group was able to successfully convert inactivated alkenes into 
fluorinated compounds using Selectfluor as the fluorine source and iron (III) oxalate 
catalyst and sodium borohydride as a hydride source. They demonstrated this method was 
successful when R1 was alkyl, R2 was hydrogen or alkyl and R3 was alkyl, amine, amide, 
or aryl. The method shows exclusive Markovnikov regioselectivity (Chatalova-Sazepin 













Early works towards the fluorination of alkynes relied on the use of gold catalysts. 
The Sadighi group reported the use of gold catalyst and vinyl fluorides to perform a 
hydrofluorination of alkynes. However, fluorination of carbon-carbon multiple bonds 
does not always result in an open-chain fluorinated product. The Gouveneur group 
performed a gold catalyzed alkoxyfluorination of alkynes. The reaction caused an 
intramolecular cyclization of the open-chain molecule to a difluorinated pyranone alpha 
position to the carbonyl and a bond formed between gold and the other alpha position. It 
was reported that protonation of the second alpha position could not be controlled and 
two final products were observed, alkoxyfluorinated pyranone and alkoxyhydrogenated 
pyranone. Gouveneur noted that without formation of the difluorine intermediate only 
hydroalkoxylation was observed (Ahlsted & Martín-Manute, 2011). 
  More recently the Martín-Manute group reported the use of iridium catalytic 
conversion of allylic alcohols to α-fluoroketones. Compounds that fluorination was 
observed in had R groups of hydrogen, alkyl, or aryl groups. They propose the final 
product is reached through an iridium-catalyzed isomerization of the alcohol and 
subsequent oxidative fluorination of the iridium-allyl complex formed. They reported all 
fluoroketones were observed as one isomer, but they were only able to produce eight 











3.3 Bioactivity of Fluorine Containing Molecules 
 Fluorine is a highly coveted element that is sought after for its set of unique 
chemical and physical properties. It forms unique bonds and can drastically change the 
characteristics of a compound. The presence of even one fluorine atom can improve the 
solubility, bioavailability, and metabolic stability of the compound, making them 
particularly useful in pharmaceuticals (Liu, 2012). Despite recent years to push drug 
molecules towards the new less known region of biological medicine and away from 
small molecule medications, fluorine-containing small molecules still remain useful and 
desirable.  
 Being the most electronegative element alters how atoms bound to it behave 
electronically. This will also affect its chemical and physical behavior. Due to its small 
size fluorine has been observed to mimic hydrogen in terms of steric requirements in 
enzyme-receptor sites. The bond fluorine forms with carbon is also met with increased 
thermal and oxidative stability. This helps increase its stability in the body, allowing it to 
reduce side effects by more selectively metabolizing at the desired locations in vivo to 
reduce side effects. The element also significantly increases lipophilicity which enhances 
its rates of absorption; the drug becomes present in higher ratios inside of the cell. 
Moving past the cell’s lipid-bilayer increases the efficiency of the drug with lower doses. 
The more fluorine is present in the molecule, such as trifluoromethyl groups, the higher 
the pharmacological activity.  
Despite its high dipole the element creates, it has not been observed to make 
halogen bonds as bromine, chlorine, and iodine containing compounds have exhibited. 
The electronegative qualities of the carbon-fluorine bond affect the chemical reactivity 
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and properties of the molecule. (Purser et. al., 2008). While halogen bonding is rarely 
plausible for fluorine, the element’s size and electronegative nature allow it to mimic 
hydrogen bonding. Its inability to participate in halogen bonding merely limits the 
functional groups it can interact with electrostatically. The increased stability of the 
carbon-fluorine bond leads to increased stability during absorption and metabolism. The 
more stable the molecule is, the longer it can stay active in the body to deliver therapeutic 
effects. Conversely, this can also aid in drug delivery of prodrugs. The more stable the 
prodrug is, the longer it can remain inactive in the body. This allows for more specific 
activity of therapeutics. Alterations to the time a drug remains active in the body allow 
for fewer doses required for the patient, lowering the number of doses the patient is 
required to take (Hagmann, 2008). 
3.4 Pharmaceutical Relevance 
 Fluorine started to enter the stage of pharmaceuticals in the 1940’s. The original 
goal was to fluorinate medicinally relevant molecules. As just discussed, the presence of 
fluorine enhances the bioavailability and bioactivity of the molecule. The element is also 
capable of interacting with enzymes in vivo at the receptor site in a manner that mimics 
that of hydrogen (Filler & Saha, 2009, & Purser et. al., 2008). The use of it in specific 
categories of medications became more popular; the pursuit to incorporate it into 
anesthesia, steroids, nonsteroidal anti-inflammatories, and CNS medications began (Filler 
& Saha, 2009, & Purser et. al., 2008).   
 The incorporation of fluorine into steroids has had the greatest impact on a drug 
many people take. Anti-inflammatory agents containing fluorine were originally 
pioneered to be more efficacious than cortisone and cortisol, and combat electrolyte 
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retention as an undesirable side effect. More important is the means of administration of 
corticosteroids. These are usually used as topical agents requiring a high lipid-water ratio 
to be absorbed into the cell. Due to its chemical properties to help increase lipophilicity 
the presence of fluorine favorably enhances that ratio, leading to a highly effective 
treatment for conditions such as allergic rhinitis and asthma (Filler & Saha, 2009, & 
Purser et. al., 2008).  
 Included in anti-inflammatory agents are over-the-counter drugs, nonsteroidal 
anti-inflammatory agents (NSAIDS). These drugs include medications such as 
Ibuprofen®️, Aspirin®️, and Aleve®️. The search for methods to synthesize these 
medications began in the 1960’s due to the limitations of current cortical steroids, and to 
surpass the effectiveness of salicylates, such as Aspirin®️. Research into this area of 
pharmaceutical chemistry has brought to market two fluorine-containing NSAIDS - 
diflunisal (Dolobid®️) and flurbiprofen (Froben®️) (Filler & Saha, 2009, & Purser et. al., 













The addition of the bulky benzene group and fluorine contributes to increasing the 
lipophilicity of these compounds. Benzene may participate in pi-pi stacking interactions  
with aromatic groups at the receptor. Due to the integrity of the pharmacophore, the 
benzoic acid group, each drug can have similar effects in the body. While drugs such as 
Aspirin®️ and Ibuprofen®️ are frequently prescribed and used, these drugs are useful in 
the alleviation of pain due to osteoarthritis. They have also found in clinical trials these 
compounds, while more expensive to produce than their competitors, have greater in vitro 
activity, longer analgesic efficacy, and reduced gastrointestinal irritation (Filler & Saha, 
2009, & Hagmann, 2008).  
 The small size of fluorine also leads to production of smaller molecules, 
characterized by being less than 500g/mol in size. With these smaller biologically 
relevant molecules, there is a greater chance they can pass the blood-brain barrier and 
exhibit CNS activity. Treatment of mental illness becomes exponentially improved with 
drugs capable of this in vivo activity. The use of fluorine in these compounds has been 
crucial in the synthesis of viable and effective psychotropics. At the start of the 
exploration of medications for mental illness trifluoromethyl and fluoro-substituted aryl 
compounds were used as the main sources of fluorine in the production of psychiatric 
medications. The lipophilicity of the compounds, coupled with their small size, enhanced 
their absorption allowing for ease of cross the blood-brain barrier. Fluorine-incorporated 
medication can be prescribed for several psychiatric diseases, with some of the most 
well-known being benzodiazepines (Flurazepam®️) and antidepressant fluoxetine 
(Prozac®️) (Filler & Saha, 2009, & Purser et. al., 2008).  
63 
 
 Despite fluorine lacking the ability to participate in halogen bonding, 
organofluorines still make up about 63% of the available pharmaceutical drugs 
containing halogens available on the market today. This is due to the interesting chemical 
and physical properties fluorine adds to a molecule (Xu et. al., 2014, & Hagmann, 2008). 
The element has found its way into nearly every drug type on the market. It now 
represents drugs such as anticancer and antiviral drugs, biologics, antibiotics, statins, and 
more (Filler & Saha, 2009, Purser et. al., 2008, & Hagmann, 2008).  
3.5 Results and Discussion 
 The success of brominating α-alkene compounds prompted the exploration of the 
same reaction with fluorinating agents. Due to the difficulty many chemists have met 
when fluorinating substrates it was decided the concentration of the photocatalyst would 
be increased to the original 5.0mol%. The reaction was attempted using α-methylstyrene 
and para-methylstyrene to determine if the reaction would proceed. While α-
methylstyrene showed no conversion after 48 hours under visible light conditions, para-
methylstyrene showed complete conversion of the starting material with good product 
yield. Substrates with alpha substituents were not included in the scope due to no 
conversion observed when α-methylstyrene was tested. 
 As with the reaction brominating styrenes and stilbenes regioisomeric ratios have 
been observed here as well. The reaction was attempted with the use of molecular sieves 
to understand if the presence of water in the reaction mixture was affecting the outcome 
of the reaction. The opposite was found, as the reaction did not show any conversion by 
crude NMR when molecular sieves were used. Given this new information the 
exploration of the scope began. 
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 However, it was quickly discovered that while the reaction would proceed with 
compounds with electron-donating groups, the reaction did not appear to be successful 
when compounds with electron-withdrawing groups are used. Due to this optimization of 
the reaction was revisited with a wider array of conditions to be tested. However due to 
the coronavirus pandemic the GML lab was incapable of completing the optimization 
studies at this time.  
Conditions to be tested include the fluorine source, solvent, solvent concentration, 
equivalence of additives (fluorine source and HOSA), catalyst used, and catalyst 
concentrations. Fluorine sources available to be tested are iron (III) fluorine, zinc (IV) 
fluoride, chromium (III) fluoride, and cesium fluoride. Due to the decreased conversion 
when acetonitrile is used as the solvent it is not planned to be tested again at this time. 
However, the solvents chosen at this time were determined based on the polarity of the 
solvent as well as whether it is aromatic or not. This is to determine the effects polarity 
and aromaticity have on the overall conversion of this method. The remaining 
concentrations and equivalences will be to attempt to find the best ratios to yield the 
highest conversion. Catalysts to test are identical to the catalysts tested in the brominating 
method. 
Despite the pitfalls of purification that accompanied bromination of the same 
substrates, the fluorinated products did not show the same issues. The product mixtures 
of para-methylstyrene were easily separated through automated standard silica gel 
chromatography. This may be attributed to the electronegative nature of fluorine; 
compounds fluorine is bound to tend to be more polar than their other halogen 
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counterparts. The separation by TLC from the starting materials was much more drastic, 
simplifying the isolation process of the regioisomeric mixture.  
 Due to the similarities in reaction, reactivity, and product formation between the 
halogenating reactions it is hypothesized that both reactions follow a similar radical-
mediated mechanism. The differences in starting material conversion and regioisomer 
ratios may be explained by the differences in chemical properties between fluorine and 
bromine. Not only is their atomic size drastically different, the electronegative properties 
of fluorine are vastly larger than that of bromine. As such, the electronic activity of the 
aromatic ring and the electron-withdrawing and electron-donating qualities of the 
substituents to the ring, may play an important role in the halogenation ratios that occur 









































 As previously mentioned the completion of optimization reactions and the true 
validity of this method have not been explored at this time due to the COVID-19 
pandemic. However, preliminary reactions to test the legitimacy of the hypothesized 
method shows promise in the fluorination of styrenes and stilbenes. Given its similarity to 
the bromination method discussed in the previous chapter, it will be interesting to see if 
the regioisomer ratios of their respective products differ and by how much. Testing the 
reaction with α-methylstyrene and para-methylstyrene showed no conversion with α-
methylstyrene despite para-methylstyrene showing excellent yields (based on crude 
NMR). What’s more, the effects electron-donating and -withdrawing groups may have on 
the product formation and ratios has yet to be explored. Completion of the optimization 
and scope may help understand how important these electronic effects are to successful 
fluorination.  
3.7 Experimental 
Reagents were obtained from Aldrich Chemical, Acros Organics or Alfa Aesar 
and used without further purification.  Reactions were performed in 20- mL glass vials 
with magnetic stirring. TLC was performed on 0.25 mm E. Merck silica gel 60 F254 
plates and visualized under UV light (254 nm) or by staining with potassium 
permanganate (KMnO4). Automated chromatography was performed on a ISOLERA 
Prime instrument with 10 g. SNAP silica gel normal phase cartridges using a flow rate of 
12.0 mL/min and a gradient of 0–30% EtOAc in Heptanes over 20 column volumes with 
UV detection at 254 nm. NMR spectra were recorded on Varian Mercury II 400 MHz 
Spectrometer at 24 °C in CDCl3 unless otherwise indicated. Chemical shifts are 
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expressed in ppm relative to solvent signals: CDCl3 (1 H, 7.23 ppm; 13C, 77.0 ppm; 
coupling constants are expressed in Hz). 
3.7.1 General Methods for the Synthesis of Aromatic Fluorides  
In a 20mL glass vial, 100mg styrene or stilbene, 2 mmol eq. of hydroxylamine-o-
sulfonic acid, and 1 mmol eq. of iron (II) fluoride were dissolved in .1M toluene with 
1mL 5.0mol% ruthenium tris(2,2’-bipyridyl) chloride dissolved in acetonitrile. The 
mixture was stirred on high at room temperature in an enclosed visible light box with a 
ventilation fan for 48 hours. Iron and ruthenium reaction complexes were removed from 
the mixture by vacuum filtration through 1:1 silica:celite and washed with excess 1% 
methanol in ethyl acetate. The mixture was concentrated by rotary evaporation to afford 
the crude product. Filtration by silica gel with 0-30% EtOAc in Heptanes over 20 column 
volumes provided the desired fluorinated product mixture in good yield.  
3.7.2 Synthesis of Aromatic Fluorides  
Due to the COVID-19 pandemic of 2020 exploration of the optimization and full 
scope of this method was unable to be fulfilled. The methods detailed are variables to be 
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